Amgen

Bayer, Amgen Face Price Cuts as German Panel Expands Drug Review

Bayer, Amgen Face Price Cuts as German Panel Expands Drug Review

Bloomberg

Cipla steamrolls into Enbrel market with biosimilar of Amgen drug

Cipla steamrolls into Enbrel market with biosimilar of Amgen drug

Fierce Pharma

Did Someone Say Kickbacks? Amgen Pays $29M Over Aranesp Marketing

Did Someone Say Kickbacks? Amgen Pays $29M Over Aranesp Marketing

Pharmalot

Hikma to Keep Injectable-Drug Unit After Completing Review

Hikma to Keep Injectable-Drug Unit After Completing Review

Bloomberg

Array's Up-Coming Value Enhancing Catalysts

Array's Up-Coming Value Enhancing Catalysts

Seeking Alpha

Is Celgene's Apremilast A Potential Blockbuster Or Not?

Is Celgene's Apremilast A Potential Blockbuster Or Not?

Seeking Alpha

Spectrum Progresses with SPI-2012

Spectrum Progresses with SPI-2012

Yahoo/Zacks

Bradway salary jumps in first year as Amgen's CEO

Bradway salary jumps in first year as Amgen's CEO

News and Observer, NC

Amgen: Long-Term Buy After A Pull Back

Amgen: Long-Term Buy After A Pull Back

Seeking Alpha

Amgen

Can New Psoriasis Drugs Scratch Investors' Itch?

Can New Psoriasis Drugs Scratch Investors' Itch?

Investors.com